Orchard Therapeutics North America is a biopharmaceutical company based in Massachusetts that develops gene and cell therapies. Its filings show it lobbies on health and pharmacy issues, including getting metachromatic leukodystrophy (a rare genetic disorder) added to the Recommended Uniform Screening Panel for newborn screening and on Medicare/Medicaid related matters. It has reported about $90,000 in lobbying over five filings.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
MICHAEL CORCORAN
The latest disclosures for this client.
CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
Q2CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
ROBERT BLAIR
CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
Q4CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
Q3CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
RACORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
Q2CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS
RR